BSE filing, BSE: 544629. Summary written from the filing by ALFA Finder's alert engine.
Ravelcare Ltd: key numbers
- Share price
- ₹90.00
- Market cap
- ₹61.73 Cr
- Revenue (annual)
- ₹26.95 Cr
- Net profit (annual)
- ₹5.15 Cr
- P/E (TTM)
- 12.0×Sector 38.6×
- Promoter holding
- 72.94%
- FII holding
- 1.82%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ravelcare Ltd
All →Ravelcare Annual General Meeting
Ravelcare Ltd submitted the proceedings of its 8th AGM held on September 23, 2026. Items covered adoption of audited FY26 financials and re-appointment of the MD, WTD, and a retiring director.
Ravelcare Annual Report
Ravelcare Limited has filed its Annual Report for the fiscal year 2025-26, along with the notice for its 8th Annual General Meeting.
Ravelcare Product Launch
Ravelcare Limited launched the 'Ravel PRO' and AI diagnostic skincare range to expand its market presence. These new products are available across major e-commerce platforms.
Ravelcare Management Change
Ravelcare Limited has announced the re-appointment of its Executive Directors, Mr. Ayush Varma and Mr. Maheshkumar Varma, along with Secretarial Auditor M/s. VTSN & Associates LLP.
Ravelcare Board Meeting Outcome
Ravelcare Limited announced board meeting outcomes, including the re-appointment of its Managing Director, Whole-time Director, and Secretarial Auditor, plus shifting its registered office and AGM notice.
Ravelcare H2 FY26 Results: Net Profit ₹2 Cr, Up 33.3% YoY
Ravelcare Ltd reported revenue from operations of ₹12.6 Cr (-13.7% YoY) and net profit of ₹2 Cr (+33.3% YoY) for H2 FY26.
- Key figure
- Net profit ₹2 Cr · +33.3% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.